[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @doepke_michel Michel Doepke Michel Doepke posts on X about $bpmc, $lly, $nvo, pfe the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::1350720698591936515/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +36% - X Year XXXXXXXXX +293% ### Mentions: XX [#](/creator/twitter::1350720698591936515/posts_active)  - X Week XXX +12% - X Month XXX -XX% - X Months XXX +59% - X Year XXXXX +353% ### Followers: XXXXX [#](/creator/twitter::1350720698591936515/followers)  - X Week XXXXX +0.73% - X Month XXXXX +2.60% - X Months XXXXX +18% - X Year XXXXX +45% ### CreatorRank: XXXXXXX [#](/creator/twitter::1350720698591936515/influencer_rank)  ### Social Influence [#](/creator/twitter::1350720698591936515/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% [finance](/list/finance) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [currencies](/list/currencies) XXXX% [countries](/list/countries) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [$bpmc](/topic/$bpmc) 3.14%, [$lly](/topic/$lly) 3.14%, [$nvo](/topic/$nvo) 3.14%, [pfe](/topic/pfe) 1.96%, [$vrna](/topic/$vrna) 1.96%, [$sny](/topic/$sny) 1.96%, [$mrk](/topic/$mrk) 1.96%, [$pfe](/topic/$pfe) 1.96%, [$nvs](/topic/$nvs) 1.57%, [$mdgl](/topic/$mdgl) XXXX% **Top accounts mentioned or mentioned by** [@hexagonpurus](/creator/undefined) [@biopharmiq](/creator/undefined) [@hexagonasa](/creator/undefined) [@aktionaer](/creator/undefined) [@winterlars](/creator/undefined) [@drrichjlaw](/creator/undefined) [@r2discovery](/creator/undefined) [@felixschreibe13](/creator/undefined) [@joserestonva](/creator/undefined) [@yachmod](/creator/undefined) [@laurenzfoehn](/creator/undefined) [@airliquidegroup](/creator/undefined) [@seattletimes](/creator/undefined) [@ramlars77](/creator/undefined) [@optionshawk](/creator/undefined) [@doepkemichel](/creator/undefined) [@wystrachgmbh](/creator/undefined) [@duisburgde](/creator/undefined) [@evfcfaddict](/creator/undefined) [@trader53](/creator/undefined) **Top assets mentioned** [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Eli Lilly and Company (LLY)](/topic/$lly) [Novo-Nordisk (NVO)](/topic/$nvo) [Synthetify (SNY)](/topic/$sny) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Pfizer, Inc. (PFE)](/topic/$pfe) [Novartis AG (NVS)](/topic/$nvs) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Danaher Corporation (DHR)](/topic/$dhr) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Intra-Cellular Therapies Inc. (ITCI)](/topic/$itci) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Johnson & Johnson (JNJ)](/topic/$jnj) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Sanofi (SNY)](/topic/sanofi) [Iqvia Holdings Inc (IQV)](/topic/$iqv) [Medpace Holdings, Inc. Common Stock (MEDP)](/topic/$medp) [Charles River Laboratories Intl. Inc (CRL)](/topic/$crl) [Biogen Inc (BIIB)](/topic/$biib) [SpringWorks Therapeutics, Inc. Common Stock (SWTX)](/topic/$swtx) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [United Community Banks, Inc. (UCB)](/topic/$ucb) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [AbbVie Inc (ABBV)](/topic/$abbv) [HexCube (HEX)](/topic/$hex) [Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [RayzeBio, Inc. Common Stock (RYZB)](/topic/$ryzb) [pNetwork (PNT)](/topic/$pnt) [AstraZeneca PLC (AZN)](/topic/$azn) [Dawn Protocol (DAWN)](/topic/$dawn) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [Vertex Protocol (VRTX)](/topic/$vrtx) [GSK plc (GSK)](/topic/$gsk) [Moderna Inc (MRNA)](/topic/$mrna) [Club Atletico Independiente Fan Token (CAI)](/topic/$cai) [Plug Power, Inc. (PLUG)](/topic/$plug) [Molina Healthcare, Inc. (MOH)](/topic/$moh) [UnitedHealth Group (UNH)](/topic/$unh) ### Top Social Posts [#](/creator/twitter::1350720698591936515/posts) --- Top posts by engagements in the last XX hours "My colleague @laurenz_foehn wrote about the latest deal between $HPUR and @airliquidegroup. #hydrogen #Wasserstoff #AirLiquide @HexagonPurus"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1395999460627525632) 2021-05-22 07:06:22 UTC 4845 followers, XX engagements "$BPMC leader in the SM niche acquired by $SNY $VRNA with novel treatment for COPD acquired by $MRK In my opinion the next logical takeover candidate among the commercial stage biotechs is $MDGL. First mover in the field of NASH. Blockbuster in the making. Could be in the same price range. $PFE $BMY $NVS"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942896827302326622) 2025-07-09 10:41:15 UTC 4844 followers, 6534 engagements "Quo vadis #NovoNordisk Current analyst estimates imply sales growth of around XX% and operating profit growth of around XX% - P/E XX for '25 and XX for '26. Despite all the headwinds even if Novo Nordisk cancels the upper end of its forecast estimates are unlikely to fall any further. Good risk/reward ratio here imo. $NVO $NOVOB $LLY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1946176905088057607) 2025-07-18 11:55:07 UTC 4841 followers, 1378 engagements "$SRPT Announces Voluntary Pause of ELEVIDYS Shipments in the U.S"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947524897514606878) 2025-07-22 05:11:33 UTC 4855 followers, 1156 engagements "Goldman initiated $UCB with a "Buy" and PT $250"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945351992856973665) 2025-07-16 05:17:12 UTC 4843 followers, XXX engagements "$ARWR on fire. The market is pricing in some obesity fantasy. I mentioned it in March 👇"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1861826050956693934) 2024-11-27 17:34:56 UTC 4843 followers, 1472 engagements "$NVO $NOVOB #NovoNordisk - #Amycretin results from a phase 1b/2a randomised controlled study. "High proportion of discontinuations". $LLY $VKTX"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1943632096611737889) 2025-07-11 11:22:57 UTC 4854 followers, 13.5K engagements "$ITCI $BPMC $VIGL #Carmot #Capstan - X Women Biotech Leaders Bagging Billions in M&A Dollars"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1946971858609279069) 2025-07-20 16:33:58 UTC 4855 followers, 1688 engagements "Sino with an interesting move to acquire LaNova for up to $951M. $MRK entered into Exclusive Global License for LM-299 An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines back in November - $588M upfront $BNTX $SMMT $PFE"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945105697462513908) 2025-07-15 12:58:31 UTC 4854 followers, 2616 engagements "More #RNAi therapies are likely to come. Let the science speak a big win for patients. $ARWR $ALNY $DRNA $NVO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1597671462277898242) 2022-11-29 19:18:54 UTC 4843 followers, XX engagements "$NBIX Presents One-Year Data Showing Sustained Efficacy of CRENESSITY (crinecerfont) in Adult Patients at ENDO 2025. Should be supportive for a strong launch. Q2 earnings on Wednesday July 30"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944753998977802410) 2025-07-14 13:40:59 UTC 4845 followers, 1261 engagements "@OptionsHawk #Sartorius with an cautious outlook today - shares down XX% in Germany. $DHR"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947631935762616649) 2025-07-22 12:16:53 UTC 4855 followers, XXX engagements "$CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944729228684976503) 2025-07-14 12:02:34 UTC 4843 followers, 4740 engagements "$BONEX #Bonesupport published a strong Q2 report today. Gross margin stable at stunning XXXX percent net cash position tripled. Torbjrn Skld will take over as the new CEO on September X 2025. Emil did a great job. 👏👏👏"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945115281774325839) 2025-07-15 13:36:36 UTC 4845 followers, 3444 engagements "#Otsuka and #Lundbeck Issue Statement on FDA Advisory Committee Meeting for the Treatment of PTSD. FDA adcomm on Friday voted 10-to-1 against beexpiprazole"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947177507637088755) 2025-07-21 06:11:09 UTC 4855 followers, 1732 engagements "This is huge. $HPUR shares up XX% in Oslo. $HEX @HexagonPurus @aktionaer"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1488487925008449538) 2022-02-01 12:22:30 UTC 4845 followers, XX engagements "#Radiopharma space never sleeps: Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy. $TLX"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942921234661982486) 2025-07-09 12:18:14 UTC 4839 followers, XXX engagements "$TLX Gozellix Receives Permanent HCPCS Code. $LNTH"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942863963210846225) 2025-07-09 08:30:40 UTC 4843 followers, 1030 engagements "#Shionogi puts more than $600M on the table for Swiss biotech's antibiotic program. #BioVersys"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1940334134934880400) 2025-07-02 08:58:02 UTC 4847 followers, XXX engagements "$PTGX Announces Nomination of PN-477 an Oral and Injectable GLP-1R GIPR and GCGR Triple Agonist Peptide Development Candidate for Obesity. $NVO $LLY $VKTX"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1940038371616657641) 2025-07-01 13:22:46 UTC 4854 followers, 1183 engagements "#Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945352745789075532) 2025-07-16 05:20:12 UTC 4855 followers, 1109 engagements "$MTSR up XX% in five days. Best performing #obesity play in the past few weeks. Something brewing $LLY $NVO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945117923896365381) 2025-07-15 13:47:06 UTC 4844 followers, 5606 engagements "$DHR Reports Second Quarter 2025 Results. Double beat and guidance raised but CFO to retire. Also cautious #Sartorius outlook weigh on the shares"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947606405231354021) 2025-07-22 10:35:26 UTC 4855 followers, XXX engagements "$CANTA #Cantargia +195% - announces the acquisition of its CAN10 IL1RAP immunology program by Otsuka Pharmaceutical. $33M upfront + up to $580M milestones + earn-out payments from global product sales"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945120204935098798) 2025-07-15 13:56:10 UTC 4845 followers, 1778 engagements "$SNY announces extension of $BPMC tender offer"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945727986428203093) 2025-07-17 06:11:16 UTC 4855 followers, 3761 engagements "Alpha-based theranostics are on the horizon. $RYZB $BMY $PNT $LLY $FUSN $AZN $NVS (Source: #IonBeamApplications)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1909537070671905134) 2025-04-08 09:21:29 UTC 4842 followers, XXX engagements "$MEDP double beat guidance raised. The CRO company signals a turnaround in the order level and the net book-to-bill ratio. Shares up XX% after hours. Positive signal for the whole industry. $CRL $IQV $EVT $GUBRA $DHR"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947537149898731914) 2025-07-22 06:00:14 UTC 4855 followers, 2023 engagements "$LXEO Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia. $BIIB"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942177269046239522) 2025-07-07 11:01:59 UTC 4846 followers, XXX engagements "$ITCI $SWTX and $BPMC gone. I will add three new commercial stage biotechs to this potential M&A list: $TGTX - MS product: Briumvi $DAWN - Oncology product: Ojemda $BBIO - rare genetic diseases / oncology product: Attruby/Beyonttra"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1930565301923377649) 2025-06-05 10:00:10 UTC 4854 followers, 20.7K engagements "$MRK to acquire $VRNA - many people are just talking about the sales potential in #COPD which is a clear and huge blockbuster opportunity. But #VeronaPharma is running more interesting trials with ensifentrine. $VRTX $REGN"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942903503195615462) 2025-07-09 11:07:47 UTC 4846 followers, 2560 engagements "$SNY to acquire Vicebio expanding respiratory vaccines pipeline - upfront payment of $115B with potential milestone payments of up to $450M. #RSV $GSK $MRNA $PFE"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947531362547675226) 2025-07-22 05:37:14 UTC 4855 followers, 2889 engagements "$SMMT key message after the latest Ivonescimab data set. The crucial point remains the validity of Chinese study data imho. #Akeso $BNTX $PFE $MRK"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1928405118678147127) 2025-05-30 10:56:22 UTC 4843 followers, 6456 engagements "$BONEX #Bonesupport reiterated with a "Buy" and SEK XXX PT at ABGSC. EBIT estimates up for 25e-27e"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945367490604744776) 2025-07-16 06:18:47 UTC 4845 followers, 2156 engagements "$BMY Announces Topline Results from Phase X INDEPENDENCE Trial for Reblozyl (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia - did not meet its primary endpoint"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1946163853567414770) 2025-07-18 11:03:15 UTC 4854 followers, 2043 engagements "$MDGL Secures $XXX Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH - M&A speculations should be cooling off (temporary)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947644991569866855) 2025-07-22 13:08:46 UTC 4855 followers, 1694 engagements "$URGN Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947265768560664902) 2025-07-21 12:01:52 UTC 4855 followers, 4084 engagements "$CAI Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure Blood-Based Assay for Multi-Cancer Early Detection Minimal Residual Disease and Therapy Selection. $GRAL $PSNL"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942532700872818961) 2025-07-08 10:34:21 UTC 4845 followers, 1292 engagements "$PFE $BMY to Offer Blockbuster Blood Thinner at Discount. Maybe $JNJ and $BAYN should do the same with #Xarelto to defend themselves against generic competition"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945795379670171950) 2025-07-17 10:39:04 UTC 4854 followers, 1442 engagements "#Hydrogen accelerator $NEL $ITM $CWR $PLUG $BLDP $PCELL $HPUR"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1501299152566771714) 2022-03-08 20:49:45 UTC 4845 followers, XX engagements "$NVO $NOVOB #NovoNordisk CagriSema XXX mg / XXX mg demonstrated XXXX% mean weight reduction in adults with overweight or obesity in REDEFINE X published in New England Journal of Medicine. $LLY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1936772827966836934) 2025-06-22 13:06:40 UTC 4843 followers, 7836 engagements "$VSTM moving. Still own the whole position despite the setback below $X. Undervalued imo"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1946231477001179306) 2025-07-18 15:31:58 UTC 4855 followers, XXX engagements "$NBIX shares up XX% after Q1 earnings strong Crenessity launch; guidance reaffirmed"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1919486620786364868) 2025-05-05 20:17:27 UTC 4844 followers, 2833 engagements "$MDGL up X% after really important patent news - protection until 2044. Reminds me of $ITCI when the patent overhang was lifted and then a short time later $JNJ acquired the company"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945462465019437397) 2025-07-16 12:36:11 UTC 4844 followers, 13.2K engagements "$ZBH Announces Definitive Agreement to Acquire $MGRM Expanding Robotics Suite with Autonomous Solutions"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944721699712233973) 2025-07-14 11:32:39 UTC 4843 followers, XXX engagements "$XBI It is time for a move higher in biotech says Mizuho's Jared Holz $GILD $INSM $BMRN $BBIO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942589665611243647) 2025-07-08 14:20:42 UTC 4847 followers, 1740 engagements "$JSPR down 40%: Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria. $BPMC $CLDX (I own shares of $CLDX)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942188000076599661) 2025-07-07 11:44:37 UTC 4844 followers, 5729 engagements "Old but gold: #AATD market. $MREO $ARWR $DRNA $NVO $INBX $SNY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1764266820800844236) 2024-03-03 12:29:23 UTC 4843 followers, 2144 engagements "$CAPR Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy. $SRPT"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1943628273541353834) 2025-07-11 11:07:45 UTC 4842 followers, 13.8K engagements "Barclays initiated $ZEAL with a "Buy" and DKK XXX PT. $GUBRA $NVO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942452210987569187) 2025-07-08 05:14:30 UTC 4854 followers, XXX engagements "Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA (ustekinumab-hmny) Injection a biosimilar referencing STELARA (ustekinumab) Injection. $JNJ $FYB"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1927244185360289978) 2025-05-27 06:03:14 UTC 4843 followers, XXX engagements "$MEDP double beat. The CRO company signals a turnaround in the order level and the net book-to-bill ratio. Shares up XX% after hours. Positive signal for the whole industry. $CRL $IQV $EVT $GUBRA $DHR"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947534097234203036) 2025-07-22 05:48:06 UTC 4854 followers, XXX engagements "$LLY FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease. $BIIB"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942928876176646426) 2025-07-09 12:48:36 UTC 4846 followers, XXX engagements "$NVS got access to #Pluvicto with the acquisition of #Endocyte back in 2018. This year #Novartis will generate approximately the purchase price with Pluvicto sales alone. Probably one of the best takeovers by Novartis in recent years which has quickly paid off"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945723900895117732) 2025-07-17 05:55:02 UTC 4842 followers, 6776 engagements "$CAMX #Camurus new ATH - dip after Q2 results was a clear buying opportunity. Great growth story and broad pipeline. $LLY deal confirmed the potential of the FluidCrystal platform technology"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947201658821190012) 2025-07-21 07:47:07 UTC 4855 followers, 2027 engagements "$COGT positive top-line results from the registration-directed Part X of the SUMMIT clinical trial of bezuclastinib in patients with non-advanced systemic mastocytosis (NonAdvSM). NDA submission to FDA expected by end of 2025. $BPMC $SNY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942180954354688318) 2025-07-07 11:16:38 UTC 4844 followers, 1936 engagements "Back in December 2019 $SRPT got $1.15B upfront from $RHHBY. Now the marketcap of the company after the 3rd death is just $1.35B. $850M Cash"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1946288350073098337) 2025-07-18 19:17:57 UTC 4855 followers, 1484 engagements "$RHHBY update on astegolimab in #COPD. #FAIL $MRK $VRNA $REGN"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1947169743506432190) 2025-07-21 05:40:18 UTC 4855 followers, 1984 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@doepke_michel Michel Doepke
Michel Doepke posts on X about $bpmc, $lly, $nvo, pfe the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +36%
- X Year XXXXXXXXX +293%
Mentions: XX #
- X Week XXX +12%
- X Month XXX -XX%
- X Months XXX +59%
- X Year XXXXX +353%
Followers: XXXXX #
- X Week XXXXX +0.73%
- X Month XXXXX +2.60%
- X Months XXXXX +18%
- X Year XXXXX +45%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXXXX% finance XXXX% cryptocurrencies XXXX% currencies XXXX% countries XXXX% travel destinations XXXX%
Social topic influence $bpmc 3.14%, $lly 3.14%, $nvo 3.14%, pfe 1.96%, $vrna 1.96%, $sny 1.96%, $mrk 1.96%, $pfe 1.96%, $nvs 1.57%, $mdgl XXXX%
Top accounts mentioned or mentioned by @hexagonpurus @biopharmiq @hexagonasa @aktionaer @winterlars @drrichjlaw @r2discovery @felixschreibe13 @joserestonva @yachmod @laurenzfoehn @airliquidegroup @seattletimes @ramlars77 @optionshawk @doepkemichel @wystrachgmbh @duisburgde @evfcfaddict @trader53
Top assets mentioned Blueprint Medicines Corporation (BPMC) Eli Lilly and Company (LLY) Novo-Nordisk (NVO) Synthetify (SNY) Merck & Co., Inc. (MRK) Pfizer, Inc. (PFE) Novartis AG (NVS) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Bristol-Myers Squibb Co (BMY) Danaher Corporation (DHR) Sarepta Therapeutics, Inc. (SRPT) Arrowhead Research Corporation (ARWR) Viking Therapeutics, Inc (VKTX) Intra-Cellular Therapies Inc. (ITCI) Summit Therapeutics Inc. Common Stock (SMMT) BridgeBio Pharma, Inc. Common Stock (BBIO) Johnson & Johnson (JNJ) Metsera, Inc. Common Stock (MTSR) Neurocrine Biosciences, Inc. (NBIX) Sanofi (SNY) Iqvia Holdings Inc (IQV) Medpace Holdings, Inc. Common Stock (MEDP) Charles River Laboratories Intl. Inc (CRL) Biogen Inc (BIIB) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Axsome Therapeutics, Inc (AXSM) Regeneron Pharmaceuticals Inc (REGN) United Community Banks, Inc. (UCB) Alnylam Pharmaceuticals, Inc. (ALNY) Corcept Therapeutics Inc. (CORT) AbbVie Inc (ABBV) HexCube (HEX) Lantheus Holdings, Inc (LNTH) Protagonist Therapeutics, Inc (PTGX) RayzeBio, Inc. Common Stock (RYZB) pNetwork (PNT) AstraZeneca PLC (AZN) Dawn Protocol (DAWN) TG Therapeutics, Inc. (TGTX) Vertex Protocol (VRTX) GSK plc (GSK) Moderna Inc (MRNA) Club Atletico Independiente Fan Token (CAI) Plug Power, Inc. (PLUG) Molina Healthcare, Inc. (MOH) UnitedHealth Group (UNH)
Top Social Posts #
Top posts by engagements in the last XX hours
"My colleague @laurenz_foehn wrote about the latest deal between $HPUR and @airliquidegroup. #hydrogen #Wasserstoff #AirLiquide @HexagonPurus"
@doepke_michel on X 2021-05-22 07:06:22 UTC 4845 followers, XX engagements
"$BPMC leader in the SM niche acquired by $SNY $VRNA with novel treatment for COPD acquired by $MRK In my opinion the next logical takeover candidate among the commercial stage biotechs is $MDGL. First mover in the field of NASH. Blockbuster in the making. Could be in the same price range. $PFE $BMY $NVS" @doepke_michel on X 2025-07-09 10:41:15 UTC 4844 followers, 6534 engagements
"Quo vadis #NovoNordisk Current analyst estimates imply sales growth of around XX% and operating profit growth of around XX% - P/E XX for '25 and XX for '26. Despite all the headwinds even if Novo Nordisk cancels the upper end of its forecast estimates are unlikely to fall any further. Good risk/reward ratio here imo. $NVO $NOVOB $LLY" @doepke_michel on X 2025-07-18 11:55:07 UTC 4841 followers, 1378 engagements
"$SRPT Announces Voluntary Pause of ELEVIDYS Shipments in the U.S" @doepke_michel on X 2025-07-22 05:11:33 UTC 4855 followers, 1156 engagements
"Goldman initiated $UCB with a "Buy" and PT $250" @doepke_michel on X 2025-07-16 05:17:12 UTC 4843 followers, XXX engagements
"$ARWR on fire. The market is pricing in some obesity fantasy. I mentioned it in March 👇" @doepke_michel on X 2024-11-27 17:34:56 UTC 4843 followers, 1472 engagements
"$NVO $NOVOB #NovoNordisk - #Amycretin results from a phase 1b/2a randomised controlled study. "High proportion of discontinuations". $LLY $VKTX" @doepke_michel on X 2025-07-11 11:22:57 UTC 4854 followers, 13.5K engagements
"$ITCI $BPMC $VIGL #Carmot #Capstan - X Women Biotech Leaders Bagging Billions in M&A Dollars" @doepke_michel on X 2025-07-20 16:33:58 UTC 4855 followers, 1688 engagements
"Sino with an interesting move to acquire LaNova for up to $951M. $MRK entered into Exclusive Global License for LM-299 An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines back in November - $588M upfront $BNTX $SMMT $PFE" @doepke_michel on X 2025-07-15 12:58:31 UTC 4854 followers, 2616 engagements
"More #RNAi therapies are likely to come. Let the science speak a big win for patients. $ARWR $ALNY $DRNA $NVO" @doepke_michel on X 2022-11-29 19:18:54 UTC 4843 followers, XX engagements
"$NBIX Presents One-Year Data Showing Sustained Efficacy of CRENESSITY (crinecerfont) in Adult Patients at ENDO 2025. Should be supportive for a strong launch. Q2 earnings on Wednesday July 30" @doepke_michel on X 2025-07-14 13:40:59 UTC 4845 followers, 1261 engagements
"@OptionsHawk #Sartorius with an cautious outlook today - shares down XX% in Germany. $DHR" @doepke_michel on X 2025-07-22 12:16:53 UTC 4855 followers, XXX engagements
"$CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV" @doepke_michel on X 2025-07-14 12:02:34 UTC 4843 followers, 4740 engagements
"$BONEX #Bonesupport published a strong Q2 report today. Gross margin stable at stunning XXXX percent net cash position tripled. Torbjrn Skld will take over as the new CEO on September X 2025. Emil did a great job. 👏👏👏" @doepke_michel on X 2025-07-15 13:36:36 UTC 4845 followers, 3444 engagements
"#Otsuka and #Lundbeck Issue Statement on FDA Advisory Committee Meeting for the Treatment of PTSD. FDA adcomm on Friday voted 10-to-1 against beexpiprazole" @doepke_michel on X 2025-07-21 06:11:09 UTC 4855 followers, 1732 engagements
"This is huge. $HPUR shares up XX% in Oslo. $HEX @HexagonPurus @aktionaer" @doepke_michel on X 2022-02-01 12:22:30 UTC 4845 followers, XX engagements
"#Radiopharma space never sleeps: Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy. $TLX" @doepke_michel on X 2025-07-09 12:18:14 UTC 4839 followers, XXX engagements
"$TLX Gozellix Receives Permanent HCPCS Code. $LNTH" @doepke_michel on X 2025-07-09 08:30:40 UTC 4843 followers, 1030 engagements
"#Shionogi puts more than $600M on the table for Swiss biotech's antibiotic program. #BioVersys" @doepke_michel on X 2025-07-02 08:58:02 UTC 4847 followers, XXX engagements
"$PTGX Announces Nomination of PN-477 an Oral and Injectable GLP-1R GIPR and GCGR Triple Agonist Peptide Development Candidate for Obesity. $NVO $LLY $VKTX" @doepke_michel on X 2025-07-01 13:22:46 UTC 4854 followers, 1183 engagements
"#Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT" @doepke_michel on X 2025-07-16 05:20:12 UTC 4855 followers, 1109 engagements
"$MTSR up XX% in five days. Best performing #obesity play in the past few weeks. Something brewing $LLY $NVO" @doepke_michel on X 2025-07-15 13:47:06 UTC 4844 followers, 5606 engagements
"$DHR Reports Second Quarter 2025 Results. Double beat and guidance raised but CFO to retire. Also cautious #Sartorius outlook weigh on the shares" @doepke_michel on X 2025-07-22 10:35:26 UTC 4855 followers, XXX engagements
"$CANTA #Cantargia +195% - announces the acquisition of its CAN10 IL1RAP immunology program by Otsuka Pharmaceutical. $33M upfront + up to $580M milestones + earn-out payments from global product sales" @doepke_michel on X 2025-07-15 13:56:10 UTC 4845 followers, 1778 engagements
"$SNY announces extension of $BPMC tender offer" @doepke_michel on X 2025-07-17 06:11:16 UTC 4855 followers, 3761 engagements
"Alpha-based theranostics are on the horizon. $RYZB $BMY $PNT $LLY $FUSN $AZN $NVS (Source: #IonBeamApplications)" @doepke_michel on X 2025-04-08 09:21:29 UTC 4842 followers, XXX engagements
"$MEDP double beat guidance raised. The CRO company signals a turnaround in the order level and the net book-to-bill ratio. Shares up XX% after hours. Positive signal for the whole industry. $CRL $IQV $EVT $GUBRA $DHR" @doepke_michel on X 2025-07-22 06:00:14 UTC 4855 followers, 2023 engagements
"$LXEO Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia. $BIIB" @doepke_michel on X 2025-07-07 11:01:59 UTC 4846 followers, XXX engagements
"$ITCI $SWTX and $BPMC gone. I will add three new commercial stage biotechs to this potential M&A list: $TGTX - MS product: Briumvi $DAWN - Oncology product: Ojemda $BBIO - rare genetic diseases / oncology product: Attruby/Beyonttra" @doepke_michel on X 2025-06-05 10:00:10 UTC 4854 followers, 20.7K engagements
"$MRK to acquire $VRNA - many people are just talking about the sales potential in #COPD which is a clear and huge blockbuster opportunity. But #VeronaPharma is running more interesting trials with ensifentrine. $VRTX $REGN" @doepke_michel on X 2025-07-09 11:07:47 UTC 4846 followers, 2560 engagements
"$SNY to acquire Vicebio expanding respiratory vaccines pipeline - upfront payment of $115B with potential milestone payments of up to $450M. #RSV $GSK $MRNA $PFE" @doepke_michel on X 2025-07-22 05:37:14 UTC 4855 followers, 2889 engagements
"$SMMT key message after the latest Ivonescimab data set. The crucial point remains the validity of Chinese study data imho. #Akeso $BNTX $PFE $MRK" @doepke_michel on X 2025-05-30 10:56:22 UTC 4843 followers, 6456 engagements
"$BONEX #Bonesupport reiterated with a "Buy" and SEK XXX PT at ABGSC. EBIT estimates up for 25e-27e" @doepke_michel on X 2025-07-16 06:18:47 UTC 4845 followers, 2156 engagements
"$BMY Announces Topline Results from Phase X INDEPENDENCE Trial for Reblozyl (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia - did not meet its primary endpoint" @doepke_michel on X 2025-07-18 11:03:15 UTC 4854 followers, 2043 engagements
"$MDGL Secures $XXX Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH - M&A speculations should be cooling off (temporary)" @doepke_michel on X 2025-07-22 13:08:46 UTC 4855 followers, 1694 engagements
"$URGN Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer" @doepke_michel on X 2025-07-21 12:01:52 UTC 4855 followers, 4084 engagements
"$CAI Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure Blood-Based Assay for Multi-Cancer Early Detection Minimal Residual Disease and Therapy Selection. $GRAL $PSNL" @doepke_michel on X 2025-07-08 10:34:21 UTC 4845 followers, 1292 engagements
"$PFE $BMY to Offer Blockbuster Blood Thinner at Discount. Maybe $JNJ and $BAYN should do the same with #Xarelto to defend themselves against generic competition" @doepke_michel on X 2025-07-17 10:39:04 UTC 4854 followers, 1442 engagements
"#Hydrogen accelerator $NEL $ITM $CWR $PLUG $BLDP $PCELL $HPUR" @doepke_michel on X 2022-03-08 20:49:45 UTC 4845 followers, XX engagements
"$NVO $NOVOB #NovoNordisk CagriSema XXX mg / XXX mg demonstrated XXXX% mean weight reduction in adults with overweight or obesity in REDEFINE X published in New England Journal of Medicine. $LLY" @doepke_michel on X 2025-06-22 13:06:40 UTC 4843 followers, 7836 engagements
"$VSTM moving. Still own the whole position despite the setback below $X. Undervalued imo" @doepke_michel on X 2025-07-18 15:31:58 UTC 4855 followers, XXX engagements
"$NBIX shares up XX% after Q1 earnings strong Crenessity launch; guidance reaffirmed" @doepke_michel on X 2025-05-05 20:17:27 UTC 4844 followers, 2833 engagements
"$MDGL up X% after really important patent news - protection until 2044. Reminds me of $ITCI when the patent overhang was lifted and then a short time later $JNJ acquired the company" @doepke_michel on X 2025-07-16 12:36:11 UTC 4844 followers, 13.2K engagements
"$ZBH Announces Definitive Agreement to Acquire $MGRM Expanding Robotics Suite with Autonomous Solutions" @doepke_michel on X 2025-07-14 11:32:39 UTC 4843 followers, XXX engagements
"$XBI It is time for a move higher in biotech says Mizuho's Jared Holz $GILD $INSM $BMRN $BBIO" @doepke_michel on X 2025-07-08 14:20:42 UTC 4847 followers, 1740 engagements
"$JSPR down 40%: Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria. $BPMC $CLDX (I own shares of $CLDX)" @doepke_michel on X 2025-07-07 11:44:37 UTC 4844 followers, 5729 engagements
"Old but gold: #AATD market. $MREO $ARWR $DRNA $NVO $INBX $SNY" @doepke_michel on X 2024-03-03 12:29:23 UTC 4843 followers, 2144 engagements
"$CAPR Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy. $SRPT" @doepke_michel on X 2025-07-11 11:07:45 UTC 4842 followers, 13.8K engagements
"Barclays initiated $ZEAL with a "Buy" and DKK XXX PT. $GUBRA $NVO" @doepke_michel on X 2025-07-08 05:14:30 UTC 4854 followers, XXX engagements
"Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA (ustekinumab-hmny) Injection a biosimilar referencing STELARA (ustekinumab) Injection. $JNJ $FYB" @doepke_michel on X 2025-05-27 06:03:14 UTC 4843 followers, XXX engagements
"$MEDP double beat. The CRO company signals a turnaround in the order level and the net book-to-bill ratio. Shares up XX% after hours. Positive signal for the whole industry. $CRL $IQV $EVT $GUBRA $DHR" @doepke_michel on X 2025-07-22 05:48:06 UTC 4854 followers, XXX engagements
"$LLY FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease. $BIIB" @doepke_michel on X 2025-07-09 12:48:36 UTC 4846 followers, XXX engagements
"$NVS got access to #Pluvicto with the acquisition of #Endocyte back in 2018. This year #Novartis will generate approximately the purchase price with Pluvicto sales alone. Probably one of the best takeovers by Novartis in recent years which has quickly paid off" @doepke_michel on X 2025-07-17 05:55:02 UTC 4842 followers, 6776 engagements
"$CAMX #Camurus new ATH - dip after Q2 results was a clear buying opportunity. Great growth story and broad pipeline. $LLY deal confirmed the potential of the FluidCrystal platform technology" @doepke_michel on X 2025-07-21 07:47:07 UTC 4855 followers, 2027 engagements
"$COGT positive top-line results from the registration-directed Part X of the SUMMIT clinical trial of bezuclastinib in patients with non-advanced systemic mastocytosis (NonAdvSM). NDA submission to FDA expected by end of 2025. $BPMC $SNY" @doepke_michel on X 2025-07-07 11:16:38 UTC 4844 followers, 1936 engagements
"Back in December 2019 $SRPT got $1.15B upfront from $RHHBY. Now the marketcap of the company after the 3rd death is just $1.35B. $850M Cash" @doepke_michel on X 2025-07-18 19:17:57 UTC 4855 followers, 1484 engagements
"$RHHBY update on astegolimab in #COPD. #FAIL $MRK $VRNA $REGN" @doepke_michel on X 2025-07-21 05:40:18 UTC 4855 followers, 1984 engagements